Literature DB >> 9139575

Tamoxifen-induced female androgenetic alopecia in a patient with breast cancer.

J P Ayoub, V Valero, G N Hortobagyi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9139575     DOI： 10.7326/0003-4819-126-9-199705010-00033

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Hormonal therapies in young breast cancer patients: when, what and for how long?

Authors:  Alexandre Christinat; Simona Di Lascio; Olivia Pagani
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer.

Authors:  Jin Park; Ju-Ik Kim; Seok-Kweon Yun; Han-Uk Kim; Chull-Wan Ihm
Journal:  Ann Dermatol       Date:  2014-11-26       Impact factor: 1.444

Review 3.  Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer.

Authors:  Alfredo Rossi; Gemma Caro; Francesca Magri; Maria Caterina Fortuna; Marta Carlesimo
Journal:  Explor Target Antitumor Ther       Date:  2021-10-31

Review 4.  Effect of estrogens on skin aging and the potential role of SERMs.

Authors:  Susan Stevenson; Julie Thornton
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.